Efficacy of Daptomisin Versus Linezolid in the Treatment of Vancomycin Resistant Enterococcus Meningitis in an Experimental Rabbit Model

dc.contributor.authorSari, Sema
dc.contributor.authorTütüncü, Ediz
dc.contributor.authorSancak, İrem Gül
dc.contributor.authorŞencan, İrfan
dc.date.accessioned2024-11-07T10:39:47Z
dc.date.available2024-11-07T10:39:47Z
dc.date.issued2023
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjective: Acute bacterial meningitis, which has a high rate of mortality and morbidity, has emergency therapy indication. Optimal therapy must be applied at optimal duration and optimal dosage. Carriage of vancomycin resistant enterococcus (VRE) are increasingly seen and we see VRE as the cause of postoperative meningitis. How-ever, in VRE meningitis, there is no optimal treatment regimen and the disease is evaluated on a case-by-case basis. In this study, it is aimed to contribute to a treatment plan for VRE meningitis based on the experimental meningitis model. Material and Methods: In our study, after creating a VRE experimental meningitis model, daptomycin and linezolid activity was compared with control group. Daptomycin was given 15 mg/kg at one dose, linezolid was given 20 mg/kg at 2 doses every 12 hours. Groups were compared with each other for cerebrospinal fluid (CSF) cell count, culture, protein, glucose, simultaneous blood glucose. Results: In both groups, CSF pleocytosis and biochemical response were similar. In the daptomycin group 24th hour of the treatment, CSF culture was positive in 22% of the rabbits, whereas no growth was observed in linezolid and control groups. Conclusion: As a result, there is no statistically significant difference observed between daptomycin and linezolid groups. There is not a standard treatment regimen for VRE meningitis, so we couldn’t compare the antibiotics that we use in our study with the standard regimen. Due to the lack of an established treatment regimen for VRE meningitis, it was not possible to compare the efficacy of antibiotics in our study with the standard regimen. Further research should be conducted on new antibiotics, combination therapies and intrathecal-intraventricular practices. © 2023 by Türkiye Klinikleri.
dc.identifier.doi10.5336/medsci.2022-92253
dc.identifier.endpage268
dc.identifier.issn1300-0292
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85175181165
dc.identifier.scopusqualityQ4
dc.identifier.startpage261
dc.identifier.trdizinid1262782
dc.identifier.urihttps://doi.org/10.5336/medsci.2022-92253
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1262782
dc.identifier.urihttps://hdl.handle.net/11480/11215
dc.identifier.volume43
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isotr
dc.publisherTurkiye Klinikleri
dc.relation.ispartofTurkiye Klinikleri Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectdaptomycin
dc.subjectlinezolid
dc.subjectMeningitis
dc.subjectvancomycin resistant enterococcus
dc.titleEfficacy of Daptomisin Versus Linezolid in the Treatment of Vancomycin Resistant Enterococcus Meningitis in an Experimental Rabbit Model
dc.title.alternativeVankomisin Dirençli Enterokok ile Oluşturulmuş Deneysel Menenjit Modelinde Daptomisin ve Linezolidin Etkinliklerinin Karşılaştırılması
dc.typeArticle

Dosyalar